Insider Trades31 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Buy | AUPH | Kevin Tang | Chief Executive Officer | 814,606 | $15.29 | $2.1B | -16.36% | +55.71% | $12.5M | +1.30% | — | Sell Now |
| Mar 6, 2026 | Sell | AUPH | Greg Keenan | SVP, Chief Medical Officer | 8,069 | $14.32 | $2.1B | -16.36% | +55.71% | $115.5K | -4.96% | — | Sell Now |
| Mar 2, 2026 | Sell | AUPH | Stephen P. Robertson | EVP, General Counsel | 36,525 | $14.21 | $2.1B | -16.36% | +55.71% | $519.0K | -5.70% | — | Sell Now |
| Mar 2, 2026 | Sell | AUPH | Joseph M Miller | Chief Financial Officer | 37,511 | $14.21 | $2.1B | -16.36% | +55.71% | $533.0K | -5.29% | — | Sell Now |
| Mar 2, 2026 | Sell | AUPH | Matthew Maxwell Donley | Chief Operating Officer | 40,761 | $14.21 | $2.1B | -16.36% | +55.71% | $579.2K | -4.98% | — | Sell Now |
| Mar 2, 2026 | Sell | AUPH | Peter Greenleaf | Chief Executive Officer | 100,890 | $14.21 | $2.1B | -16.36% | +55.71% | $1.4M | -4.45% | — | Sell Now |
| Feb 20, 2026 | Sell | AUPH | Joseph M Miller | Chief Financial Officer | 32,424 | $14.40 | $2.1B | -16.36% | +55.71% | $466.9K | -5.50% | — | Sell Now |
| Feb 20, 2026 | Sell | AUPH | Matthew Maxwell Donley | Chief Operating Officer | 32,901 | $14.40 | $2.1B | -16.36% | +55.71% | $473.8K | -4.73% | — | Sell Now |
| Feb 20, 2026 | Sell | AUPH | Stephen P. Robertson | EVP, General Counsel | 34,638 | $14.40 | $2.1B | -16.36% | +55.71% | $498.8K | -6.69% | — | Sell Now |
| Feb 20, 2026 | Sell | AUPH | Peter Greenleaf | Chief Executive Officer | 100,171 | $14.40 | $2.1B | -16.36% | +55.71% | $1.4M | -5.43% | — | Sell Now |
| Feb 2, 2026 | Sell | AUPH | Greg Keenan | SVP, Chief Medical Officer | 11,552 | $14.53 | $2.1B | -16.36% | +55.71% | $167.9K | -8.65% | — | Sell Now |
| Jan 2, 2026 | Sell | AUPH | Joseph M Miller | Chief Financial Officer | 40,161 | $15.95 | $2.1B | -16.36% | +55.71% | $640.6K | -6.38% | — | Sell Now |
| Jan 2, 2026 | Sell | AUPH | Stephen P. Robertson | EVP, General Counsel | 40,385 | $15.95 | $2.1B | -16.36% | +55.71% | $644.1K | -7.23% | — | Sell Now |
| Jan 2, 2026 | Sell | AUPH | Matthew Maxwell Donley | Chief Operating Officer | 42,787 | $15.95 | $2.1B | -16.36% | +55.71% | $682.5K | -5.79% | — | Sell Now |
| Jan 2, 2026 | Sell | AUPH | Peter Greenleaf | Chief Executive Officer | 113,169 | $15.95 | $2.1B | -16.36% | +55.71% | $1.8M | -5.78% | — | Sell Now |
| Aug 1, 2025 | Sell | AUPH | Greg Keenan | Chief Medical Officer | 20,000 | $10.50 | $2.1B | -16.36% | +55.71% | $210.0K | -13.03% | — | Sell Now |
| Mar 7, 2025 | Sell | AUPH | Greg Keenan | Chief Medical Officer | 8,305 | $8.23 | $2.1B | -16.36% | +55.71% | $68.4K | -5.13% | — | Sell Now |
| Mar 3, 2025 | Sell | AUPH | Greg Keenan | Chief Medical Officer | 12,239 | $8.00 | $2.1B | -16.36% | +55.71% | $97.9K | -4.54% | — | Sell Now |
| Mar 3, 2025 | Sell | AUPH | Joseph M Miller | Chief Financial Officer | 118,013 | $7.96 | $2.1B | -16.36% | +55.71% | $939.6K | -8.12% | — | Sell Now |
| Mar 3, 2025 | Sell | AUPH | Stephen P. Robertson | EVP, General Counsel | 122,479 | $7.96 | $2.1B | -16.36% | +55.71% | $975.2K | -9.23% | — | Sell Now |
| Mar 3, 2025 | Sell | AUPH | Matthew Maxwell Donley | Chief Operating Officer | 124,893 | $7.96 | $2.1B | -16.36% | +55.71% | $994.4K | -7.47% | — | Sell Now |
| Mar 3, 2025 | Sell | AUPH | Peter Greenleaf | Chief Executive Officer | 360,540 | $7.96 | $2.1B | -16.36% | +55.71% | $2.9M | -7.93% | — | Sell Now |
| Aug 6, 2024 | Sell | AUPH | Scott Michael Habig | Chief Commercial Officer | 18,249 | $5.31 | $2.1B | -16.36% | +55.71% | $96.9K | -3.85% | — | Sell Now |
| Mar 6, 2024 | Sell | AUPH | Scott Michael Habig | Chief Commercial Officer | 17,777 | $5.60 | $2.1B | -16.36% | +55.71% | $99.6K | -3.61% | — | Sell Now |
| Mar 6, 2024 | Sell | AUPH | Joseph M Miller | Chief Financial Officer | 34,811 | $5.60 | $2.1B | -16.36% | +55.71% | $194.9K | -6.56% | — | Sell Now |
| Mar 6, 2024 | Sell | AUPH | Matthew Maxwell Donley | EVP, Ops & Strategy | 40,665 | $5.51 | $2.1B | -16.36% | +55.71% | $224.1K | -6.51% | — | Sell Now |
| Mar 6, 2024 | Sell | AUPH | Stephen P. Robertson | EVP, General Counsel | 57,745 | $5.60 | $2.1B | -16.36% | +55.71% | $323.4K | -11.51% | — | Sell Now |
| Mar 6, 2024 | Sell | AUPH | Peter Greenleaf | Chief Executive Officer | 126,981 | $5.60 | $2.1B | -16.36% | +55.71% | $711.1K | -7.70% | — | Sell Now |
| Feb 27, 2024 | Sell | AUPH | Volker Knappertz | EVP, Research and Development | 4,930 | $6.10 | $2.1B | -16.36% | +55.71% | $30.1K | -1.52% | — | Sell Now |
| Feb 20, 2024 | Sell | AUPH | Scott Michael Habig | Chief Commercial Officer | 15,867 | $5.48 | $2.1B | -16.36% | +55.71% | $87.0K | -3.12% | — | Sell Now |
| Feb 20, 2024 | Sell | AUPH | Volker Knappertz | EVP, Research and Development | 25,146 | $5.48 | $2.1B | -16.36% | +55.71% | $137.8K | -7.20% | — | Sell Now |